Logo-ipp

Immunopathol Persa. 2020;6(2): e16. doi: 10.34172/ipp.2020.16

Epidemiology and Prevention

Acute respiratory distress syndrome in COVID-19

Nahid Dadashzadeh 1, Saman Farshid 2 ORCID, Rohollah Valizadeh 3,4 ORCID, Mohammad Nanbakhsh 5, Mohsen Mohammad Rahimi 6 * ORCID

Cited by CrossRef: 14

1- Taghizadieh A, Mikaeili H, Ahmadi M, Valizadeh H. Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran. Respiratory Medicine Case Reports. 2020;30:101090 [Crossref]
2- Nokhodian Z, Ranjbar M, Nasri P, Kassaian N, Shoaei P, Vakili B, Rostami S, Ahangarzadeh S, Alibakhshi A, Yarian F, Javanmard S, Ataei B. Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment. J Res Med Sci. 2020;25(1):101 [Crossref]
3- Marimuthu M, Moorthy A, Ramasamy T. Diallyl Disulfide Attenuates STAT3 and NF-κB Pathway Through PPAR-γ Activation in Cerulein-Induced Acute Pancreatitis and Associated Lung Injury in Mice. Inflammation. 2022;45(1):45 [Crossref]
4- Sadeghmoghadam L, Daneshfar M, Sharifi F, Alizad V. How the first cases of COVID-19 in 10 countries become infected? A case series. Respiratory Medicine Case Reports. 2023;46:101219 [Crossref]
5- Alkhawaldeh O, Jarrar Y, Gharaibeh M, Abudahab S, Abulebdah D, Jarrar B. Alterations in the gene expression of SARS‐COV‐2 entry receptors and enzymes in lungs and hearts of controlled and uncontrolled diabetic mice. Fundamemntal Clinical Pharma. 2024;38(2):328 [Crossref]
6- Aslan A, Aslan C, Zolbanin N, Jafari R. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia. 2021;13(1) [Crossref]
7- Kouchek M, Miri M, Aghakhani K, Memarian A. ABO blood group is related to the prevalence, severity, and mortality rate of COVID-19. Medicina Clínica Práctica. 2024;7(3):100442 [Crossref]
8- Canoglu K, Saylan B. Therapeutic dosing of low-molecular-weight heparin may decrease mortality in patients with severe COVID-19 infection. Ann Saudi Med. 2020;40(6):462 [Crossref]
9- Gharebaghi N, Farshid S, Boroofeh B, Nejadrahim R, Mousavi J, Dindarian S, Mohammadi S. Evaluation of epidemiology, clinical features, prognosis, diagnosis and treatment outcomes of patients with COVID‐19 in West Azerbaijan Province. Int J Clin Pract. 2021;75(6) [Crossref]
10- Hadianfar A, Yousefi R, Delavary M, Fakoor V, Shakeri M, Lavallière M, Cheong S. Effects of government policies and the Nowruz holidays on confirmed COVID-19 cases in Iran: An intervention time series analysis. PLoS ONE. 2021;16(8):e0256516 [Crossref]
11- Mahluji S, Jalili M, Ostadrahimi A, Hallajzadeh J, Ebrahimzadeh-Attari V, Saghafi-Asl M. Nutritional management of diabetes mellitus during the pandemic of COVID-19: a comprehensive narrative review. J Diabetes Metab Disord. 2021;20(1):963 [Crossref]
12- Eskandari D, Ziaee A, Samadanifard S, Tavangar S, Tirkan A, ZaeimYekeh M. A Case Report of Cushing’s Disease Presenting With Psychosis and Muscle Weakness Postpartum. Journal of Investigative Medicine High Impact Case Reports. 2023;11 [Crossref]
13- Ghelichi-Ghojogh M, Khezri R, Rezaei F, Aljalili S, Valizadeh R, Sadighpour T. Health inequality in COVID-19 vaccination coverage. Health Science Monitor. 2023;2(1):10 [Crossref]
14- Kouchek M, Shojaei S, Amniati S, Ghaffari M, Salarian S, Miri M, Taherpour N, Masbough F, Sistanizad M. Effect of High-dose Vitamin D on IL-1β Blood Level in Patients with Moderate Stroke: A Randomized Clinical Trial. Anesth Pain Med. 2023;13(4) [Crossref]